arrow
N

Naomi Waithira

University of the Philippines System
H指数:18
被引数:2,131

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting referral need for febrile children in low-resource community settings in South and Southeast Asia

预测南亚和东南亚资源匮乏的社区环境中发热儿童的转诊需求

2026-04-290
OAAI
Single-step versus conventional injectable artesunate for severe malaria in children: an open label, non-inferiority randomized clinical trial, Democratic Republic of the Congo and United Republic of Tanzania

Gesase, S.; Onyamboko, M.; Fanello, C.; Abdul, O.; Kayembe, D.K.; Bakomba, S.B.; Minja, D.T.R.; Nzambiwishe, B.K.; Ekombolo, P.E.; Malabeja, A.; 等. 单步法与常规注射用青蒿素琥珀酸钠治疗儿童重症疟疾:一项开放标签、非劣效性随机临床试验,刚果民主共和国与坦桑尼亚联合共和国。 Bull. World Health Organ. 2026, 104, 17–27. [Google Scholar] [CrossRef]

2026-01-011
PRE
Prospective characterisation of drug-resistant bloodstream infections in Africa and Asia (ACORN2): a surveillance network assessment

非洲和亚洲耐药血流感染的预期特征研究(ACORN2):一项监测网络评估

2025-12-080
OAAI
Operational evaluation of the deployment of Malaria/CRP Duo and Dengue Duo rapid diagnostic tests for the management of febrile illness by village malaria workers in rural Cambodia

农村柬埔寨村庄疟疾工作者的发热性疾病管理中,Malaria/CRP Duo和Dengue Duo快速诊断试验部署的现场评估。

2025-05-080
OA
The aetiologies, mortality, and disability of non-traumatic coma in African children: a systematic review and meta-analysis

非创伤性昏迷在非洲儿童的病因学、死亡率和致残率:一项系统评价和荟萃分析

2025-04-220
OAAI
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
2023-10-016
OAAI
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
2023-09-066
OAAI
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
2023-09-041
OAAI
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double- blind, placebo-controlled, non-inferiority trial
2023-04-0110
OAAI
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus
2023-03-0232
OA
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
2023-01-0114
OAAI
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
2022-06-0135
OAAI
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings
2022-03-219
OAAI
Arterolane-piperaquine-mefloquine versus arterolane- piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
2021-10-0111
OAAI
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

基于青蒿素的三联联合疗法与基于青蒿素的联合疗法治疗无并发症的恶性疟原虫疟疾: 一项多中心、开放标签、随机临床试验

LANCET
IF88.5
2020-04-01202
OAAI
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

短期primaquine用于根治间日疟原虫疟疾: 一项多中心,随机,安慰剂对照的非劣效性试验

LANCET
IF88.5
2019-09-01106
OAAI
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
2019-09-01245
OAAI
Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults
2019-08-019
OAAI